DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rebetol (Ribavirin) - Malaise - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Malaise (77)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rebetol (Ribavirin) where reactions include malaise. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 77   Next >>

Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-17

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-06-13

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-14
    End date: 2012-06-28

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-07-18
    End date: 2012-07-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-05-25

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral

Other drugs received by patient: Motilium; Gasmotin; Diflorasone Diacetate; Nizatidine



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Malaise, Renal Impairment, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, unk
    Indication: Hepatitis C
    Start date: 2012-06-06

Rebetol
    Dosage: 600 mg, unk
    Administration route: Oral
    Start date: 2012-06-15
    End date: 2012-06-20

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-06-21
    End date: 2012-07-12

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06
    End date: 2012-06-14

Rebetol
    Dosage: 200 mg, qod
    Administration route: Oral
    Start date: 2012-07-13

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2012-06-08

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06
    End date: 2012-06-07

Other drugs received by patient: Lendormin; Lansoprazole; Amoban



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Malaise

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100 microgram per kilogram, unk
    Indication: Hepatitis C
    Start date: 2012-06-15
    End date: 2012-07-13

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-15

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2012-07-06
    End date: 2012-07-13

Telavic
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-15

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2012-07-06
    End date: 2012-07-13

Other drugs received by patient: Diflunisal; Januvia; Basen



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-25

Patient:

Reactions: Weight Increased, Dysgeusia, Malaise, Hepatitis C, DRY Mouth

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-09-10
    End date: 2012-03-24

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-09-10
    End date: 2012-03-30

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-10-19
    End date: 2012-03-30



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Pruritus, Hypersensitivity, Contusion, Chills, Headache, Herpes Zoster, Vascular Injury, Fatigue, Malaise, Tongue Disorder, Candidiasis, Scratch, Swelling Face, Vomiting, Tongue Oedema, Nausea, Anaemia, Hypoaesthesia, Rash, Dysgeusia, Diarrhoea, Feeling Abnormal, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Valtrex
    Dosage: unk unk, unknown
    Indication: Herpes Zoster

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-06-01



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Malaise, Vomiting, Nausea, Anaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-18

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-05-07

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-05-08
    End date: 2012-05-08

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-09
    End date: 2012-05-14

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-15

Telavic
    Dosage: 2250 mg, qd,cumulative dose 4500 mg
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-25

Telavic
    Dosage: 1000 unk, unk,cumulative dose 4500 mg
    Start date: 2012-06-13
    End date: 2012-07-09

Telavic
    Dosage: 1500 mg, qd,cumulative dose 4500 mg
    Administration route: Oral
    Start date: 2012-04-26
    End date: 2012-06-12

Other drugs received by patient: Motilium; Eurax; Allegra; Clobetasol Propionate; Predonine; Predonine



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Hepatitis C, Nausea, Anaemia, Rash, Headache, Dysgeusia, Irritability, Pruritus Generalised, Poor Quality Sleep, Malaise, Fatigue, Depression, Depressed Mood, Hypersomnia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.5 ml, unk
    Indication: Hepatitis C
    Start date: 2012-04-13

PEG-Intron
    Dosage: 0.4 ml, unk

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-13

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-11



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Malaise, Skin Disorder, Idiopathic Thrombocytopenic Purpura

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Aldactone
    Administration route: Oral

Amlodipine Besylate
    Administration route: Oral

Lasix
    Administration route: Oral

Ledolper
    Dosage: 1 tablet per day , as needed
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2012-02-07

Lickle
    Administration route: Oral

Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-04-17

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-14
    End date: 2012-03-27

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-03-13

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-28
    End date: 2012-04-19

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-07
    End date: 2012-04-17

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-04-18
    End date: 2012-04-19

Other drugs received by patient: Acetaminophen; Motilium; Rabeprazole Sodium; Gasmotin



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-17

Rebetol
    Administration route: Oral

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-06-13

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-14
    End date: 2012-06-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-05-25

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Start date: 2012-07-18
    End date: 2012-07-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral

Other drugs received by patient: Gasmotin; Nizatidine; Motilium



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Nausea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-21

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-06-17

Rebetol
    Administration route: Oral
    Start date: 2012-06-18

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-21
    End date: 2012-06-24

Telavic
    Administration route: Oral
    Start date: 2012-06-25

Other drugs received by patient: Voltaren; Mucosta



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Blood Urea Increased, Blood Creatinine Increased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-06-13

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-13

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-13
    End date: 2012-07-03

Telavic
    Administration route: Oral
    Start date: 2012-07-04



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-22

Patient:

Reactions: Weight Decreased, Visual Acuity Reduced, Weight Increased, Blood Calcium Decreased, Malaise, Fatigue, Skin Ulcer, Blood Count, Back Pain, Dyspnoea, Nausea, Anaemia, DRY Skin, Rash, Paraesthesia, Pollakiuria, Asthenia

Drug(s) suspected as cause:
Pegasys
    Dosage: 135 microgram, qw
    Start date: 2011-11-01
    End date: 2011-12-24

Pegasys
    Dosage: 180 microgram, qw
    Indication: Hepatitis C
    Start date: 2011-07-11

Rebetol
    Dosage: 800 mg, qd
    Start date: 2011-11-01
    End date: 2011-12-24

Rebetol
    Dosage: 600 mg, unk
    Start date: 2011-11-01
    End date: 2011-12-24

Rebetol
    Dosage: 1200, mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-07-11

Victrelis
    Dosage: 800 mg, tid
    Indication: Hepatitis C
    Start date: 2011-08-08



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-14
    End date: 2012-06-18

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-14
    End date: 2012-06-18

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-14
    End date: 2012-06-14

Other drugs received by patient: Allegra; Urso 250; Epinastine Hydrochloride



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Nausea, Anaemia, Insomnia, Depression, Rash, Constipation, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-22

PEG-Intron
    Dosage: 1.0mcg/kg/week
    Start date: 2012-02-29
    End date: 2012-02-29

PEG-Intron
    Dosage: 0mcg/kg

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-14

Rebetol
    Administration route: Oral
    Start date: 2012-02-15
    End date: 2012-03-07

Rebetol
    Administration route: Oral

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-28

Telavic
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-07

Telavic
    Administration route: Oral

Other drugs received by patient: [therapy Unspecified]; [therapy Unspecified]; Milmag; Senna-Mint WAF; [therapy Unspecified]



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Anaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-07-10

Rebetol
    Administration route: Oral
    Start date: 2012-05-15
    End date: 2012-05-28

Rebetol
    Administration route: Oral
    Start date: 2012-04-17

Rebetol
    Administration route: Oral
    Start date: 2012-05-29

Rebetol
    Administration route: Oral
    Start date: 2012-02-22
    End date: 2012-04-16

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-01-30

Rebetol
    Administration route: Oral
    Start date: 2012-01-31
    End date: 2012-02-21

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-01-27

Telavic
    Administration route: Oral
    Start date: 2012-01-28
    End date: 2012-02-13

Telavic
    Administration route: Oral
    Start date: 2012-02-14
    End date: 2012-02-16

Telavic
    Administration route: Oral
    Start date: 2012-02-17
    End date: 2012-04-16



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient:

Reactions: Pain, Anaemia, Furuncle, Headache, Myalgia, Dysgeusia, Fatigue, Malaise, Fungal Infection, Oral Candidiasis, Emotional Disorder, Feeling Abnormal

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: 180 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-03-23

Rebetol
    Dosage: 1000 mg in divided dose (1 in 1 d)
    Indication: Hepatitis C
    Start date: 2012-03-23

Victrelis
    Dosage: unk, tid
    Indication: Hepatitis C
    Start date: 2012-04-20

Other drugs received by patient: Wellbutrin



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-14

Patient:

Reactions: Haemoglobin Decreased, Renal Impairment, Malaise, Anaemia, Rash, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 80 ?g, qw
    Start date: 2012-03-31

Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-01-26

Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-26
    End date: 2012-02-29

Rebetol
    Dosage: 200 mg, qd
    Start date: 2012-07-12

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-08

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-15
    End date: 2012-03-22

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-31
    End date: 2012-04-06

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-01
    End date: 2012-03-07

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-24
    End date: 2012-03-30

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-04-19
    End date: 2012-05-16

Rebetol
    Dosage: 400 mg, qd
    Start date: 2012-05-17
    End date: 2012-07-11

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-08
    End date: 2012-03-21

Telavic
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-03-24
    End date: 2012-04-06

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-26
    End date: 2012-03-07

Other drugs received by patient: Clobetasol Propionate; Sedekopan; Nespo; Allopurinol; Nespo; Paxil; Celestamine TAB



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-14

Patient:

Reactions: Malaise

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-05-15

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-06
    End date: 2012-05-14

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-05-22
    End date: 2012-05-24

PEG-Intron
    Dosage: 50mcg
    Start date: 2012-06-06

PEG-Intron
    Dosage: 60 mcg/week
    Indication: Hepatitis C
    Start date: 2012-04-06
    End date: 2012-05-02

PEG-Intron
    Dosage: 50 mcg/week
    End date: 2012-05-18

PEG-Intron
    Dosage: 40 mcg/week
    Start date: 2012-05-11

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-06
    End date: 2012-04-25

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-26
    End date: 2012-05-07

Rebetol
    Administration route: Oral
    Start date: 2012-06-14

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    End date: 2012-05-24

Telavic
    Administration route: Oral
    Start date: 2012-05-15
    End date: 2012-05-21

Telavic
    Administration route: Oral
    Start date: 2012-05-22
    End date: 2012-05-23

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-06
    End date: 2012-05-14

Other drugs received by patient: Olmesartan Medoxomil; Olmesartan Medoxomil; Allopurinol



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-14

Patient:

Reactions: Malaise, Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.3mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-29

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-29

Telavic
    Administration route: Oral
    Start date: 2012-07-04

Telavic
    Administration route: Oral
    Start date: 2012-05-29
    End date: 2012-07-03

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-29

Other drugs received by patient: Olmesartan Medoxomil; Loxonin; Zolpidem; Rebamipide; Amlodipine



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-13

Patient:

Reactions: Malaise, Nausea

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-04
    End date: 2012-05-02

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-04
    End date: 2012-05-02

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-04
    End date: 2012-05-02

Other drugs received by patient: Allegra; Voltaren-XR



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-10

Patient:

Reactions: Malaise, Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-08

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-08

Rebetol
    Administration route: Oral

Rebetol
    Administration route: Oral

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-08

Telavic
    Administration route: Oral
    Start date: 2012-05-08
    End date: 2012-07-11



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Weight Decreased, Stomatitis, Nausea, Pain in Extremity, Pain, Bone Pain, Oral Discomfort, Dysgeusia, Haemoglobin Decreased, Fatigue, Malaise, DRY Mouth, Decreased Appetite, Influenza Like Illness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Rebetol
    Dosage: 600 mg, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Victrelis
    Dosage: 2400 mg, unknown
    Indication: Hepatitis C
    Start date: 2012-03-07

Other drugs received by patient: Geodon; Ferrous Sulfate TAB; Ambien; Promethazine; Prozac; Prilosec



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Blood Pressure Increased, Malaise, Chest Discomfort, Anaemia, Dizziness, Renal Pain, Asthenia

Drug(s) suspected as cause:
Pegasys

Rebetol
    Dosage: 2 df am and 3 df pm

Victrelis
    Dosage: 4 df, unk
    Administration route: Oral



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-02

Patient:

Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Dysgeusia, Malaise, Haemolytic Anaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-22

PEG-Intron
    Dosage: 1.5mcg/kg/week

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Start date: 2012-04-18
    End date: 2012-05-09

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-05-11

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-22
    End date: 2012-04-17

Telavic
    Administration route: Oral
    Start date: 2012-04-18
    End date: 2012-05-09

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-22
    End date: 2012-04-17

Telavic
    Administration route: Oral
    Start date: 2012-05-11
    End date: 2012-05-22

Other drugs received by patient: Marzulene-S; Nexium; Diovan; Azunol (Sodium Gualenate); Adalat CC; Mucosta



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-01

Patient:

Reactions: Drug Eruption, White Blood Cell Count Decreased, Depressive Symptom, Pancytopenia, Dysgeusia, Haemoglobin Decreased, Malaise, Diarrhoea, Epistaxis, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 100mcg/week
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-02-24

Rebetol
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-05

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-02-28

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-02-28

Telavic
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-05

Other drugs received by patient: Marzulene-S; Mucosta; Urso 250; Famotidine



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-01

Patient:

Reactions: Malaise, Platelet Count Decreased

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-03
    End date: 2012-06-05

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-03
    End date: 2012-06-05

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-03
    End date: 2012-06-05

Other drugs received by patient: Antebate; Prednisolone; [therapy Unspecified]



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-01

Patient:

Reactions: White Blood Cell Count Decreased, Malaise, Diarrhoea, Alopecia, Pancytopenia, Pyrexia, Headache, Neutrophil Count Decreased

Drug(s) suspected as cause:
Copegus
    Dosage: 400 mg in the morning and 200 mg in the evening
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-12-27

Interferon Beta NOS
    Indication: Hepatitis C
    Start date: 2010-09-16
    End date: 2010-09-21

Interferon Beta NOS
    Start date: 2010-10-18
    End date: 2010-12-24

Interferon Beta NOS
    Start date: 2010-09-24
    End date: 2010-10-16

Pegasys
    Dosage: 180 qw
    Indication: Hepatitis C
    Start date: 2010-12-27

Rebetol
    Dosage: 200 mg in the morning and 400 mg in the evening
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-09-16
    End date: 2010-12-24

Other drugs received by patient: Alfarol; Singulair Tablets 10mg; Advair Diskus 100 / 50; Onealfa



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Japan on 2012-07-31

Patient:

Reactions: Malaise, Nausea, Anaemia, Dizziness, Rash, Hyperuricaemia, Decreased Appetite

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-01

Antiviral (Unspecified)
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-06-03

PEG-Intron
    Dosage: 80 ?g, unknown
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-01

PEG-Intron
    Dosage: 80mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-06-01
    End date: 2012-06-22

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-01

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-01
    End date: 2012-06-21

Rebetol
    Administration route: Oral
    Start date: 2012-06-22
    End date: 2012-06-28

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-01
    End date: 2012-06-06

Telavic
    Administration route: Oral
    Start date: 2012-06-07
    End date: 2012-06-28

Other drugs received by patient: Levothyroxine Sodium; Levothyroxine Sodium; Lulicon; Equa; Amaryl; Metformin HCL; Aspara CA; Vitamin B12; Pravastatin



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-07-31

Patient:

Reactions: Malaise, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-04-15

Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-29

Paxil
    Dosage: 3 df, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paxil
    Administration route: Oral
    Indication: Adverse Event
    Start date: 2012-02-01

PEG-Intron
    Dosage: 80mcg/week
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-01

PEG-Intron
    Dosage: 1.0mcg/kg/week
    Start date: 2012-04-16
    End date: 2012-04-30

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Start date: 2012-02-29
    End date: 2012-04-15

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Start date: 2012-05-01

PEG-Intron
    Dosage: 50mcg/week
    Start date: 2012-02-08
    End date: 2012-02-15

Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Start date: 2012-02-29
    End date: 2012-04-15

Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Start date: 2012-05-01

Peginterferon Alfa-2B
    Dosage: 1.0 ?g/kg, qw
    Start date: 2012-04-16
    End date: 2012-04-30

Peginterferon Alfa-2B
    Dosage: 50 ?g/kg, qw
    Start date: 2012-02-08
    End date: 2012-02-15

Peginterferon Alfa-2B
    Dosage: 80 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-01

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-29

Rebetol
    Administration route: Oral
    Start date: 2012-02-08
    End date: 2012-02-14

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-04-09
    End date: 2012-04-15

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-07
    End date: 2012-05-13

Rebetol
    Administration route: Oral
    Start date: 2012-02-15
    End date: 2012-02-29

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-01
    End date: 2012-05-06

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-05-14

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-12

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-04-08

Rebetol
    Administration route: Oral
    Start date: 2012-01-17
    End date: 2012-02-07

Telavic
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-04-15

Telavic
    Administration route: Oral
    Start date: 2012-02-08
    End date: 2012-02-14

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-07

Telavic
    Administration route: Oral
    Start date: 2012-02-15
    End date: 2012-02-29

Other drugs received by patient: HI-Z; [composition Unspecified]; Ganaton; Primeperani; Nizatidine; Talion (Bepotastine Besylate); Magmitt; Depas; Primeperani; Ganaton; Zolpidem; Loxonin; Dogmatyl; HI-Z



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-07-31

Patient:

Reactions: Dysgeusia, Malaise, Hypoaesthesia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-05-16

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-05-22

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-05-22



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017